Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
6 studies found for:    16531616 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Antiplatelet Therapy in Acute Mild-Moderate Ischemic Stroke
Condition: Ischemic Stroke
Interventions: Drug: clopidogrel;   Drug: Aspirin
2 Completed Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA)
Condition: Arteriosclerosis
Intervention: Drug: clopidogrel (SR25990)
3 Recruiting Optimal Anti-platelet Treatment for Patients With Clopidogrel Low Response
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel;   Drug: Cilostazol
4 Terminated Pharmacodynamic Study on Efficacy of Clopidogrel With St. John's Wort
Condition: Acute Coronary Syndrome
Interventions: Drug: Placebo;   Drug: St. Johns Wort
5 Recruiting Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers
Condition: Peptic Ulcer
Interventions: Drug: proton pump inhibitor (PPI) group pantoprazole;   Drug: histamine-2 receptor antagonist group famotidine
6 Recruiting Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer
Condition: Peptic Ulcer
Interventions: Drug: histamine-2 receptor antagonist (famotidine);   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.